1. Wang, Y.M., R. Ji, W.W. Chen, S.W. Huang, Y.J. Zheng, Z.T. Yang, H.P. Qu, H. Chen, E.Q. Mao, Y. Chen, and E.Z. Chen. 2019. Paclitaxel alleviated sepsis-induced acute lung injury by activating MUC1 and suppressing TLR-4/NF-kappaB pathway. Drug Design, Development and Therapy 13: 3391–3404.
2. Zhang, H., W. Wang, H. Fang, Y. Yang, X. Li, J. He, X. Jiang, et al. 2014. GSK-3ﺧ٢ inhibition attenuates CLP-induced liver injury by reducing inflammation and hepatic cell apoptosis. Mediators of Inflammation 2014: 629507.
3. Zhang, Z., N. Han, and Y. Shen. 2020. S100A12 promotes inflammation and cell apoptosis in sepsis-induced ARDS via activation of NLRP3 inﻡ،∙ammasome signaling. Molecular Immunology 122: 38–48.
4. Chen, Y.L., G. Xu, X. Liang, J. Wei, J. Luo, G.N. Chen, X.D. Yan, X.P. Wen, M. Zhong, and X. Lv. 2016. Inhibition of hepatic cells pyroptosis attenuates CLP-induced acute liver injury. American Journal of Translational Research 8: 5685–5695.
5. Savio, L.E.B., P. de Andrade Mello, V.R. Figliuolo, T.F. de Avelar Almeida, P.T. Santana, S.D.S. Oliveira, C.L.M. Silva, L. Feldbrügge, E. Csizmadia, R.D. Minshall, M.S. Longhi, Y. Wu, S.C. Robson, and R. Coutinho-Silva. 2017. CD39 limits P2X7 receptor inflammatory signaling and attenuates sepsis-induced liver injury. Journal of Hepatology 67: 716–726.